US Stock MarketDetailed Quotes

Aclaris Therapeutics (ACRS)

Watchlist
  • 4.905
  • -0.185-3.63%
Trading May 14 10:15 ET
685.05MMarket Cap-8.76P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics (ACRS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-39.00%-18.15M
-134.68%-47.11M
-46.91%-13.13M
-149.69%-10.93M
18.90%-9.99M
37.27%-13.06M
74.37%-20.08M
-32.20%-8.94M
189.59%22M
40.34%-12.32M
Net income from continuing operations
-31.42%-19.82M
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
Depreciation and amortization
-20.31%102K
-43.74%454K
-28.67%102K
-38.55%110K
-52.89%114K
-47.33%128K
-6.49%807K
-37.28%143K
-18.26%179K
11.01%242K
Deferred tax
----
----
----
----
----
----
--0
----
----
----
Other non cash items
----
-97.43%2.3M
-99.53%400K
-87.50%100K
650.00%1.5M
-89.29%300K
541.05%89.41M
535.18%85.61M
-52.94%800K
113.33%200K
Change In working capital
16.02%-1.63M
-75.54%2.67M
425.55%3.24M
-97.61%612K
116.21%759K
78.51%-1.94M
16.33%10.92M
-107.49%-994K
909.45%25.6M
-227.37%-4.68M
-Change in receivables
-91.03%742K
----
----
79.44%6.69M
-17,083.33%-8.15M
11,134.67%8.28M
-110.75%-20K
-7,847.92%-3.72M
4,283.53%3.73M
-81.18%48K
-Change in prepaid assets
----
225.91%6.14M
----
----
-531.14%-1.18M
301.57%8.21M
-270.72%-4.88M
-207.78%-8.6M
118.56%1.43M
137.35%273K
-Change in payables and accrued expense
83.87%-1.51M
104.31%350K
-39.37%5.21M
322.05%1.67M
156.82%2.84M
14.55%-9.38M
-177.30%-8.13M
63.87%8.6M
-116.96%-753K
-220.50%-5M
-Change in other working capital
-2.52%-854K
-115.95%-3.82M
-28.04%-1.31M
---715K
---962K
---833K
--23.93M
---1.02M
----
----
Cash from discontinued investing activities
Operating cash flow
-39.00%-18.15M
-134.68%-47.11M
-46.91%-13.13M
-149.69%-10.93M
18.90%-9.99M
37.27%-13.06M
74.37%-20.08M
-32.20%-8.94M
189.59%22M
40.34%-12.32M
Investing cash flow
Cash flow from continuing investing activities
-261.79%-30.93M
169.32%48.37M
111.69%10.37M
394.81%13.83M
848.81%5.05M
13.58%19.12M
-250.95%-69.77M
-1,275.14%-88.72M
-91.41%2.8M
96.57%-674K
Net PPE purchase and sale
69.77%-13K
8.26%-111K
---24K
---23K
-250.00%-21K
68.15%-43K
90.76%-121K
--0
--0
106.06%14K
Net intangibles purchase and sale
--0
--0
----
----
--0
---833K
---35.81M
----
----
--0
Net business purchase and sale
----
---833K
--0
----
----
----
--0
--0
----
----
Net investment purchase and sale
-254.63%-30.92M
245.72%49.31M
119.64%10.39M
395.64%13.85M
836.63%5.07M
17.84%20M
-171.19%-33.84M
-762.16%-52.91M
-91.43%2.8M
96.46%-688K
Cash from discontinued investing activities
Investing cash flow
-261.79%-30.93M
169.32%48.37M
111.69%10.37M
394.81%13.83M
848.81%5.05M
13.58%19.12M
-250.95%-69.77M
-1,275.14%-88.72M
-91.41%2.8M
96.57%-674K
Financing cash flow
Cash flow from continuing financing activities
21,111.27%57.78M
-107.86%-5.86M
-103.40%-2.53M
-13,936.36%-3.04M
18.18%-9K
-400.00%-275K
179.10%74.54M
152,104.08%74.58M
125.29%22K
-100.04%-11K
Net common stock issuance
--57.88M
--0
----
----
----
--0
180.43%74.91M
--74.91M
--0
----
Proceeds from stock option exercised by employees
--151K
--0
--0
----
----
--0
-65.96%32K
--0
113.33%32K
----
Net other financing activities
9.09%-250K
-1,333.25%-5.86M
-660.96%-2.53M
-30,340.00%-3.04M
18.18%-9K
-400.00%-275K
-300.98%-409K
---333K
---10K
---11K
Cash from discontinued financing activities
Financing cash flow
21,111.27%57.78M
-107.86%-5.86M
-103.40%-2.53M
-13,936.36%-3.04M
18.18%-9K
-400.00%-275K
179.10%74.54M
152,104.08%74.58M
125.29%22K
-100.04%-11K
Net cash flow
Beginning cash position
-18.76%19.96M
-38.39%24.57M
-47.00%25.26M
11.25%25.4M
-15.30%30.36M
-38.39%24.57M
-11.92%39.88M
22.06%47.65M
-26.70%22.83M
-19.86%35.84M
Current changes in cash
50.34%8.7M
69.89%-4.61M
77.05%-5.3M
-100.59%-146K
61.91%-4.96M
243.35%5.79M
-183.53%-15.31M
-2,854.30%-23.08M
214.54%24.82M
4.16%-13.01M
End cash Position
-5.59%28.66M
-18.76%19.96M
-18.76%19.96M
-47.00%25.26M
11.25%25.4M
-15.30%30.36M
-38.39%24.57M
-38.39%24.57M
22.06%47.65M
-26.70%22.83M
Free cash flow
-30.35%-18.16M
15.68%-47.22M
70.60%-13.16M
-146.01%-10.12M
18.64%-10.01M
33.49%-13.93M
29.67%-56.01M
-521.33%-44.75M
189.28%22M
41.07%-12.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -39.00%-18.15M-134.68%-47.11M-46.91%-13.13M-149.69%-10.93M18.90%-9.99M37.27%-13.06M74.37%-20.08M-32.20%-8.94M189.59%22M40.34%-12.32M
Net income from continuing operations -31.42%-19.82M50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M
Depreciation and amortization -20.31%102K-43.74%454K-28.67%102K-38.55%110K-52.89%114K-47.33%128K-6.49%807K-37.28%143K-18.26%179K11.01%242K
Deferred tax --------------------------0------------
Other non cash items -----97.43%2.3M-99.53%400K-87.50%100K650.00%1.5M-89.29%300K541.05%89.41M535.18%85.61M-52.94%800K113.33%200K
Change In working capital 16.02%-1.63M-75.54%2.67M425.55%3.24M-97.61%612K116.21%759K78.51%-1.94M16.33%10.92M-107.49%-994K909.45%25.6M-227.37%-4.68M
-Change in receivables -91.03%742K--------79.44%6.69M-17,083.33%-8.15M11,134.67%8.28M-110.75%-20K-7,847.92%-3.72M4,283.53%3.73M-81.18%48K
-Change in prepaid assets ----225.91%6.14M---------531.14%-1.18M301.57%8.21M-270.72%-4.88M-207.78%-8.6M118.56%1.43M137.35%273K
-Change in payables and accrued expense 83.87%-1.51M104.31%350K-39.37%5.21M322.05%1.67M156.82%2.84M14.55%-9.38M-177.30%-8.13M63.87%8.6M-116.96%-753K-220.50%-5M
-Change in other working capital -2.52%-854K-115.95%-3.82M-28.04%-1.31M---715K---962K---833K--23.93M---1.02M--------
Cash from discontinued investing activities
Operating cash flow -39.00%-18.15M-134.68%-47.11M-46.91%-13.13M-149.69%-10.93M18.90%-9.99M37.27%-13.06M74.37%-20.08M-32.20%-8.94M189.59%22M40.34%-12.32M
Investing cash flow
Cash flow from continuing investing activities -261.79%-30.93M169.32%48.37M111.69%10.37M394.81%13.83M848.81%5.05M13.58%19.12M-250.95%-69.77M-1,275.14%-88.72M-91.41%2.8M96.57%-674K
Net PPE purchase and sale 69.77%-13K8.26%-111K---24K---23K-250.00%-21K68.15%-43K90.76%-121K--0--0106.06%14K
Net intangibles purchase and sale --0--0----------0---833K---35.81M----------0
Net business purchase and sale -------833K--0--------------0--0--------
Net investment purchase and sale -254.63%-30.92M245.72%49.31M119.64%10.39M395.64%13.85M836.63%5.07M17.84%20M-171.19%-33.84M-762.16%-52.91M-91.43%2.8M96.46%-688K
Cash from discontinued investing activities
Investing cash flow -261.79%-30.93M169.32%48.37M111.69%10.37M394.81%13.83M848.81%5.05M13.58%19.12M-250.95%-69.77M-1,275.14%-88.72M-91.41%2.8M96.57%-674K
Financing cash flow
Cash flow from continuing financing activities 21,111.27%57.78M-107.86%-5.86M-103.40%-2.53M-13,936.36%-3.04M18.18%-9K-400.00%-275K179.10%74.54M152,104.08%74.58M125.29%22K-100.04%-11K
Net common stock issuance --57.88M--0--------------0180.43%74.91M--74.91M--0----
Proceeds from stock option exercised by employees --151K--0--0----------0-65.96%32K--0113.33%32K----
Net other financing activities 9.09%-250K-1,333.25%-5.86M-660.96%-2.53M-30,340.00%-3.04M18.18%-9K-400.00%-275K-300.98%-409K---333K---10K---11K
Cash from discontinued financing activities
Financing cash flow 21,111.27%57.78M-107.86%-5.86M-103.40%-2.53M-13,936.36%-3.04M18.18%-9K-400.00%-275K179.10%74.54M152,104.08%74.58M125.29%22K-100.04%-11K
Net cash flow
Beginning cash position -18.76%19.96M-38.39%24.57M-47.00%25.26M11.25%25.4M-15.30%30.36M-38.39%24.57M-11.92%39.88M22.06%47.65M-26.70%22.83M-19.86%35.84M
Current changes in cash 50.34%8.7M69.89%-4.61M77.05%-5.3M-100.59%-146K61.91%-4.96M243.35%5.79M-183.53%-15.31M-2,854.30%-23.08M214.54%24.82M4.16%-13.01M
End cash Position -5.59%28.66M-18.76%19.96M-18.76%19.96M-47.00%25.26M11.25%25.4M-15.30%30.36M-38.39%24.57M-38.39%24.57M22.06%47.65M-26.70%22.83M
Free cash flow -30.35%-18.16M15.68%-47.22M70.60%-13.16M-146.01%-10.12M18.64%-10.01M33.49%-13.93M29.67%-56.01M-521.33%-44.75M189.28%22M41.07%-12.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.20%
Sample Name
Sample Code
 +14.37%
Sample Name
Sample Code
 +13.47%
4
United States Oil Fund LP
USO
+12.71%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+10.60%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.74%
Sample Name
Sample Code
 +10.13%
Sample Name
Sample Code
 +9.60%
4
Hesai
HSAI
+7.27%
5
NIO Inc
NIO
+6.56%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -